Cholesterol gallstones and bile host diverse bacterial communities with potential to promote the formation of gallstones

Microbial Pathogenesis

Volumn 83-84, Issue , 2015, Pages 57-63

  Peng, Yuhong ^a   Yang, Yang ^a   Liu, Yongkang ^b   Nie, Yuanyang ^a   Xu, Peilun ^a   Xia, Baixue ^a   Tian, Fuzhou ^c   Sun, Qun ^a  

^a SICHUAN UNIVERSITY   (China)

^b The 452nd Hospital of PLA   (China)

^c CHENGDU MILITARY GENERAL HOSPITAL   (China)

Author keywords

Bacterial community; Bile; Cholesterol gallstones; PCR DGGE; Phospholipase A2; Glucuronidase

Indexed keywords

BETA GLUCURONIDASE; PHOSPHOLIPASE A2; BACTERIAL DNA; CHOLESTEROL; RIBOSOME DNA; RNA 16S;

ACINETOBACTER JOHNSONII; ACINETOBACTER LWOFFII; ADULT; ARTICLE; BACILLUS AMYLOLIQUEFACIENS; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BILE; BRUCELLA MELITENSIS; CHOLESTEROL STONE; CITROBACTER; CLINICAL ARTICLE; CLOSTRIDIUM CLOSTRIDIOFORME; CONTROLLED STUDY; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROCOCCUS DURANS; ENTEROCOCCUS FAECIUM; ENZYME ACTIVITY; ESCHERICHIA; FEMALE; HUMAN; KLEBSIELLA OXYTOCA; LACHNOSPIRACEAE; LACTOBACILLUS; MALE; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS FLUORESCENS; PSEUDOMONAS STUTZERI; STAPHYLOCOCCUS; STAPHYLOCOCCUS EPIDERMIDIS; AGED; BACTERIUM; BIOTA; CHEMISTRY; CLASSIFICATION; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA SEQUENCE; ENZYMOLOGY; GALLSTONE; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MIDDLE AGED;

BACTERIA (MICROORGANISMS); PSEUDOMONAS;

ADULT; AGED; BACTERIA; BILE; BIOTA; CHOLESTEROL; DENATURING GRADIENT GEL ELECTROPHORESIS; DNA, BACTERIAL; DNA, RIBOSOMAL; FEMALE; GALLSTONES; HUMANS; MALE; MIDDLE AGED; PHOSPHOLIPASES A2; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA;

EID: 84930204438     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2015.05.002     Document Type: Article

References (51)

1. Van Erpecum K.J. Pathogenesis of cholesterol and pigment gallstones: an update. Clin. Res. Hepatol. Gastroenterol. 2011, 35:281-287.
2. Zeng Q., He Y., Qiang D.C., Wu L.X. Prevalence and epidemiological pattern of gallstones in urban residents in China. Eur. J. Gastroenterol. Hepatol. 2012, 24:1459.
3. Chen X.G., Liu J.Q., Peng M.H., et al. Clinical epidemiological study on intrahepatic cholelithiasis: analysis of 8585 cases. Hepatobiliary Pancreat. Dis. Int. 2003, 2:281.
4. Chen C.Y., Shiesh S.C., Lin X.Z. Biliary sludge and pigment stone formation in bile duct-ligated guinea pigs. Dig. Dis. Sci. 1999, 44:203.
5. Liu B., Beral V., Balkwill A., Green J., Sweetland S., Reeves G., et al. Gallbladder disease and use of transdermal versus oral hormone replacement therapy in postmenopausal women: prospective cohort study. Bmj 2008, 337:a386.
6. Volzke H., Baumeister S.E., Alte D., Hoffmann W., Schwahn C., Simon P., et al. Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence. Digestion 2005, 71:97-105.
7. Katsika D., Grjibovski A., Einarsson C., Lammert F., Lichtenstein P., Marschall H.U. Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs. Hepatology 2005, 41:1138-1143.
8. Jiang Z.Y., Parini P., Eggertsen G., Davis M.A., Hu H., Suo G.J., et al. Increased expression of LXR alpha, ABCG5, ABCG8, and SR-BI in the liver from normolipidemic, nonobese Chinese gallstone patients. J. Lipid Res. 2008, 49:464-472.
9. Zhang D.C., Xiang J.B., Wang L.Y., Xu Z.B., Sun L.D., Zhou F., et al. Comparative proteomic analysis of gallbladder bile proteins related to cholesterol gallstones. PloS One 2013, 8:350-352.
10. Li Y.T., Zhu X.G., Zhao X.L., An G.S., Jia H.T. Expression of aminopeptidase N and its correlation with the gallstones formation. Chin. J. Biochem. Mol. Biol. 2001, 17:425-429.
11. Maki T. Pathogenesis of calcium bilirubinate gallstone: role of E. coli, β-glucuronidase and coagulation by inorganic ions, polyelectrolytes and agitation. Ann. Surg. 1996, 164:90-100.
12. Wang L.M., Shen W.L., Wen J., An X., Cao L.Y., Wang B.Q. An animal model of black pigment gallstones caused by nanobacteria. Dig. Dis. Sci. 2006, 51(6):1126-1132.
13. Chabriere E., Gonzalez D., Azza S., Durand P., Shiekh F.A., Moal V., et al. Fetuin is the key for nanon self-propagation. Microb. Pathog. 2014, 73:25-30.
14. Swidsinski A., Khilkin M., Pahlig H., Swidsinski S., Priem F. Time dependent changes in the concentration and type of bacterial sequences found in cholesterol gallstones. Hepatology 1998, 27:662-665.
15. Chen G.P., Zhu L.M., Cai D. Research on bacterial infection in gallbladder in cholesterol gallstone patients. J. Hepatopancreatobiliary Surg. 2007, 19:158-160. 10.3969/j.issn.1007-1954.2007.03.007.
16. Stewart L.M., Smith A.L., Pellegrini C.A., Motson R.W., Way L.W. Pigment gallstones form as a composite of bacterial microcolonies and pigment solids. Ann. Surg. 1987, 206:242-249.
17. Fremont-Rahl J.J., Ge Z., Umana C., Whary M.T., Taylor N.S., Muthupalani S., et al. An analysis of the role of the indigenous microbiota in cholesterol gallstone pathogenesis. PloS One 2013, 8:e70657.
18. Zhu L.M., Zhang H., Li J., Wang X.Z., Cai D., Zhang Y.L. Study on the mechanism of pronucleation of cholesterol crystal formation by bacteria. J. Hepatopancreatobiliary Surg. 2009, 21:122-125. 10.3969/j.issn.1007-1954.2009.02.012.
19. Ho K. Rapid purification of beta-glucuronidase from human liver by immunoaffinity chromatography employing specific murine monoclonal igg binding to tresyl-activated agarose. Protein Expr. Purif. 1991, 2:63-65.
20. Kano M., Shoda J., Irimura T., Ueda T., Iwasaki R., Urasaki T., et al. Effects of long-term ursodeoxycholate administration on expression levels of secretory low-molecular-weight phospholipases A2 and mucin genes in gallbladders and biliary composition in patients with multiple cholesterol stones. Hepatology 1998, 28:302-313.
21. Nikaido H., Pages J.M. Broad-specificity efflux pumps and their role in multidrug resistance of gram-negative bacteria. FEMS Microbiol. Rev. 2012, 36:340-363.
22. Lin J., Sahin O., Michel L.O., Zhang Q. Critical role of multidrug efflux pump CmeABC in bile resistance and in vivo colonization of Campylobacter jejuni. Infect. Immun. 2003, 71:4250-4259.
23. Alrefai W.A., Gill R.K. Bile acid transporters: structure, function, regulation and pathophysiological implications. Pharm. Res. 2007, 24:1803-1823.
24. Begley M., Gahan C.G.M., Hill C. The interaction between bacteria and bile. Fm Microbiol. Rev. 2005, 29:625-651.
25. Szakacs G., Varadi A., Ozvegy-Laczka C., Sarkadi B. The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox). Drug Discov. Today 2008, 13:379-393.
26. Endo A., Okada S. Monitoring the lactic acid bacterial diversity during shochu fermentation by PCR-denaturing gradient gel electrophoresis. J. Biosci. Bioeng. 2005, 99:216-221.
27. Mamlouk D., Hidalgo C., Torija M.J., Gullo M. Evaluation and optimisation of bacterial genomic DNA extraction for no-culture techniques applied to vinegars. Food Microbiol. 2011, 28:1374-1379.
28. Garcia-Armisen T., Papalexandratou Z., Hendryckx H., Camu N., Vrancken G., Vuyst L., et al. Diversity of the total bacterial community associated with Ghanaian and Brazilian cocoa bean fermentation samples as revealed by a 16 S rRNA gene clone library. Appl. Microbiol. Biotechnol. 2010, 87:2281-2292.
29. Swidsinski A., Schlien P., Pernthaler A., Gottschalk U., Barlehner E., Decker G., et al. Bacterial biofilm within diseased pancreatic and biliary tracts. Gut 2005, 54:388-395.
30. Portincasa P., Moschetta A., Palasciano G. Cholesterol gallstone disease. Lancet 2006, 368:230-239.
31. Azian M., Hapizah M.N., Khalid B., Khalid Y., Rosli A., Jamal R., et al. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and familial defective apolipoprotein B100 (FDB). Malays. J. Pathol. 2006, 28:7-15.
32. Ying Y., Lv Z.M., Min H., Cheng J. Dynamic changes of microbial community diversity in a photohydrogen producing reactor monitored by PCR-DGGE. J. Environ. Sci 2008, 9:1118-1125.
33. Cao X.H., Bai X.L. Determination of β-Glucuronidase activity produced by E.coli. J. Chin. Inst. Food Sci. Technol. 2003, 3:82-85. 10.3969/j.issn.1009-7848.2003.04.019.
34. Oguntoyinbo F.A., Tourlomousis P., Gasson M.J., Narbad A. Analysis of bacterial communities of traditional fermented West African cereal foods using culture independent methods. Int. J. Food Microbiol. 2011, 145:205-210.
35. Honda K., Littman D.R. The microbiome in infectious disease and inflammation. Annu. Rev. Immunol. 2012, 30:759-795.
36. Wu T., Zhang Z., Liu B., Hou D., Liang Y., Zhang J., et al. Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in largescale study. BMC Genomics 2013, 14:669. 10.1186/1471-2164-14-669.
37. Su Y., Wu S.D., Jin J.Z., Zhang Z.H., Fan Y. Role of intestinal barrier in pathogenesis of pigment gallstone in a guinea pig modelm. Hepatobiliary Pancreat. Dis. Int. 2006, 5:443-448.
38. Rajilic-Stojanovic M., Vos W.M.D. The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol. Rev. 2014, 38:996-1047.
39. Lightfoot Y.L., Mohamadzadeh M. Tailoring gut immune responses with lipoteichoic acid-deficient Lactobacillus acidophilus. Front. Immunol. 2013, 4:25.
40. Paixao T.A., Roux C.M., Hartigh A.B., Sankaran-Walters S., Dandekar S., Santos R.L., et al. Establishment of systemic Brucella melitensis infection through the digestive tract requires urease, the type IV secretion system, and lipopolysaccharide O antigen. Infect. Immun. 2009, 77:4197-4208.
41. Ferrero M.C., Fossati C.A., Rumbo M., Baldi P.C. Brucella invasion of human intestinal epithelial cells elicits a weak proinflammatory response but a significant CCL20 secretion. FEMS Immunol. Med. Microbiol. 2012, 66:45-57.
42. Swidsinski A., Ludwig W., Pahlig H., Priem F. Molecular genetic evidence of bacterial colonization of cholesterol gallgallstones. Gastroenterology 1995, 108:860-864.
43. Lee D.K., Tarr P.I., Haigh W.G., Lee S.P. Bacterial DNA in mixed cholesterol gallstones. Am. J. Gastroenterol. 1999, 94:3502-3506.
44. Kwon W., Jang J.Y., Kim E.C., Park J.W., Han I.W., Kang M.J., et al. Changing trend in bile microbiology and antibiotic susceptibilities: over 12 years of experience. Infection 2013, 41:93-102.
45. Yang B., Zhu S.D., Zhao Y.G., Yue H., Du X.J., Li Y.S., et al. Immunological electron microscopic study on relationship between hepatocytic endogenous β-glucuronidase and pigment stone formation. Chin. J. Hepatobiliary Surg. 2000, 6:123-125.
46. Li N., Xiao L.J., Cheng S.W., Xiao B.L., Cheng W.B., Li Q.Y. The changes of β-Glucuronidase in rabbit model with calcium bilirubinate stone. J. WCUMS 1990, 21:185-187.
47. Vitetta L., Best S.P., Sali A. Single and multiple cholesterol gallstones and the influence of bacteria. Med. Hyp. 2000, 55:502-506.
48. Ma W.J., Zhou Y., Shrestha A., Mao H., Li F.Y., Cheng N.S., et al. Applying chemical bile duct embolization to achieve chemical hepatectomy in hepatolithiasis: a further experimental study. J. Surg. Res. 2014, 187:113-121.
49. Shoda J., Kano M., Asano T., Irimura T., Ueda T., Iwasaki R., et al. Secretory low-molecular-weight phospholipases A2 and their specific receptor in bile ducts of patients with intrahepatic calculi: factors of chronic proliferative cholangitis. Hepatology 1999, 29:1026-1036.
50. Sampaio J.L.M., Ribeiro V.B., Campos J.C., Rozales F.P., Magagnin C.M., Falci D.R., et al. Detection of OXA-370, an OXA-48-related class D β-lactamase, in Enterobacter hormaechei from Brazil. Antimicrob. Agents Chemother. 2014, 58.
51. Dierikx C.M., Duijkeren E.V., Schoormans A.H.W., Essen-Zandbergen A.V., Veldman K., Kant A., et al. Occurrence and characteristics of extended-spectrum-β-lactamase- and AmpC-producing clinical isolates derived from companion animals and horses. J. Antimicrob. Chemother. 2012, 67:1368-1374.